Cargando…
COVID-19 Drug Discovery Using Intensive Approaches
Since the infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported in China during December 2019, the coronavirus disease 2019 (COVID-19) has spread on a global scale, causing the World Health Organization (WHO) to issue a warning. While novel vaccines a...
Autores principales: | Asai, Ayumu, Konno, Masamitsu, Ozaki, Miyuki, Otsuka, Chihiro, Vecchione, Andrea, Arai, Takahiro, Kitagawa, Toru, Ofusa, Ken, Yabumoto, Masami, Hirotsu, Takaaki, Taniguchi, Masateru, Eguchi, Hidetoshi, Doki, Yuichiro, Ishii, Hideshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215413/ https://www.ncbi.nlm.nih.gov/pubmed/32325767 http://dx.doi.org/10.3390/ijms21082839 |
Ejemplares similares
-
State-of-the-Art Technology of Model Organisms for Current Human Medicine
por: Konno, Masamitsu, et al.
Publicado: (2020) -
Immuno-Surgical Management of Pancreatic Cancer with Analysis of Cancer Exosomes
por: Takeda, Yu, et al.
Publicado: (2020) -
Impact of One-Carbon Metabolism-Driving Epitranscriptome as a Therapeutic Target for Gastrointestinal Cancer
por: Takeda, Yu, et al.
Publicado: (2021) -
Single-molecule RNA sequencing for simultaneous detection of m6A and 5mC
por: Ohshiro, Takahito, et al.
Publicado: (2021) -
Computational healthcare: Present and future perspectives (Review)
por: Asai, Ayumu, et al.
Publicado: (2021)